Le mode de vie influence-t-il le risque d'allergie ?
Oui, un mode de vie sain peut réduire le risque d'allergies alimentaires.
Mode de viePrévention des allergies
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Agglutinine cacahuète : Questions médicales les plus fréquentes",
"headline": "Agglutinine cacahuète : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Agglutinine cacahuète : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-14",
"dateModified": "2025-12-06",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Agglutinine cacahuète"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Lectines végétales",
"url": "https://questionsmedicales.fr/mesh/D037121",
"about": {
"@type": "MedicalCondition",
"name": "Lectines végétales",
"code": {
"@type": "MedicalCode",
"code": "D037121",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.765.678"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Agglutinine cacahuète",
"alternateName": "Peanut Agglutinin",
"code": {
"@type": "MedicalCode",
"code": "D019887",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Sigbjørn Berentsen",
"url": "https://questionsmedicales.fr/author/Sigbj%C3%B8rn%20Berentsen",
"affiliation": {
"@type": "Organization",
"name": "From the Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany (A.R.); Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Cà Granda Ospedale Maggiore Policlinico, Milan, Italy (W.B.); the Centre for Waldenström's Macroglobulinaemia and Related Conditions, University College London Hospitals National Health Service Foundation Trust, London (S.D.); the Thrombosis and Hemostasis Center, Saitama Medical University Hospital, Saitama, Japan (Y.M.); the Division of Hematology, MedStar Georgetown University Hospital, Washington, DC (C.M.B.); the Department of Internal Medicine, Henri-Mondor University Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris-Est Créteil, Créteil, France (M.M.); the Division of Hematology, Massachusetts General Hospital, Harvard Medical School, Boston (D.J.K.), Bioverativ, Cambridge (J.F.), and Sanofi, Waltham (X.J., S.L., C.R., J.M.-A., W.H.) - all in Massachusetts; the Department of Clinical Pharmacology, Medical University of Vienna, Vienna (B.J.); and the Section for Hematology, Department of Medicine, Haukeland University Hospital, Bergen (T.H.A.T.), and the Department of Research and Innovation, Haugesund Hospital, Haugesund (S.B.) - both in Norway."
}
},
{
"@type": "Person",
"name": "Bernd Jilma",
"url": "https://questionsmedicales.fr/author/Bernd%20Jilma",
"affiliation": {
"@type": "Organization",
"name": "From the Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany (A.R.); Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Cà Granda Ospedale Maggiore Policlinico, Milan, Italy (W.B.); the Centre for Waldenström's Macroglobulinaemia and Related Conditions, University College London Hospitals National Health Service Foundation Trust, London (S.D.); the Thrombosis and Hemostasis Center, Saitama Medical University Hospital, Saitama, Japan (Y.M.); the Division of Hematology, MedStar Georgetown University Hospital, Washington, DC (C.M.B.); the Department of Internal Medicine, Henri-Mondor University Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris-Est Créteil, Créteil, France (M.M.); the Division of Hematology, Massachusetts General Hospital, Harvard Medical School, Boston (D.J.K.), Bioverativ, Cambridge (J.F.), and Sanofi, Waltham (X.J., S.L., C.R., J.M.-A., W.H.) - all in Massachusetts; the Department of Clinical Pharmacology, Medical University of Vienna, Vienna (B.J.); and the Section for Hematology, Department of Medicine, Haukeland University Hospital, Bergen (T.H.A.T.), and the Department of Research and Innovation, Haugesund Hospital, Haugesund (S.B.) - both in Norway."
}
},
{
"@type": "Person",
"name": "Lois L Hoyer",
"url": "https://questionsmedicales.fr/author/Lois%20L%20Hoyer",
"affiliation": {
"@type": "Organization",
"name": "Department of Pathobiology, University of Illinois at Urbana-Champaign, Urbana, IL, United States."
}
},
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Matthew Greenhawt",
"url": "https://questionsmedicales.fr/author/Matthew%20Greenhawt",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatrics, Section of Allergy and Immunology, Children's Hospital Colorado, University of Colorado Denver School of Medicine, 13123 East 16th Avenue, Anschutz Medical Campus, Box 518, Denver, CO, USA. Matthew.Greenhawt@childrenscolorado.org."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Detergent induced structural perturbations in peanut agglutinin: insights from spectroscopic and molecular dynamic simulation studies.",
"datePublished": "2023-12-15",
"url": "https://questionsmedicales.fr/article/38099333",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/07391102.2023.2294382"
}
},
{
"@type": "ScholarlyArticle",
"name": "Sutimlimab for Cold Agglutinin Disease.",
"datePublished": "2024-09-01",
"url": "https://questionsmedicales.fr/article/39328891",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.6004/jadpro.2024.15.6.4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Sutimlimab for the Treatment of Cold Agglutinin Disease.",
"datePublished": "2023-05-02",
"url": "https://questionsmedicales.fr/article/37153870",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/HS9.0000000000000879"
}
},
{
"@type": "ScholarlyArticle",
"name": "Peanut (",
"datePublished": "2024-08-30",
"url": "https://questionsmedicales.fr/article/39290750",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.fochx.2024.101791"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cost-effectiveness of sutimlimab in cold agglutinin disease.",
"datePublished": "2024-05-11",
"url": "https://questionsmedicales.fr/article/38733355",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/ajh.27358"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines végétales",
"item": "https://questionsmedicales.fr/mesh/D010940"
},
{
"@type": "ListItem",
"position": 5,
"name": "Lectines végétales",
"item": "https://questionsmedicales.fr/mesh/D037121"
},
{
"@type": "ListItem",
"position": 6,
"name": "Agglutinine cacahuète",
"item": "https://questionsmedicales.fr/mesh/D019887"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Agglutinine cacahuète - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Agglutinine cacahuète",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-02-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Agglutinine cacahuète",
"description": "Comment diagnostiquer une allergie à l'agglutinine cacahuète ?\nQuels tests sont utilisés pour l'agglutinine cacahuète ?\nLes symptômes peuvent-ils aider au diagnostic ?\nQuelle est l'importance de l'historique médical ?\nPeut-on utiliser des tests d'allergie standard ?",
"url": "https://questionsmedicales.fr/mesh/D019887#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Agglutinine cacahuète",
"description": "Quels sont les symptômes d'une allergie à l'agglutinine cacahuète ?\nL'anaphylaxie est-elle un symptôme possible ?\nLes symptômes apparaissent-ils rapidement ?\nY a-t-il des symptômes digestifs associés ?\nLes symptômes varient-ils d'une personne à l'autre ?",
"url": "https://questionsmedicales.fr/mesh/D019887#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Agglutinine cacahuète",
"description": "Comment prévenir une allergie à l'agglutinine cacahuète ?\nLes enfants peuvent-ils développer une allergie aux arachides ?\nDes tests de dépistage sont-ils recommandés ?\nLes parents doivent-ils être vigilants ?\nLes allergies croisées sont-elles possibles ?",
"url": "https://questionsmedicales.fr/mesh/D019887#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Agglutinine cacahuète",
"description": "Quel est le traitement principal pour l'allergie à l'agglutinine cacahuète ?\nDes médicaments peuvent-ils aider en cas de réaction ?\nComment gérer une réaction anaphylactique ?\nY a-t-il des traitements à long terme ?\nLes immunothérapies sont-elles efficaces ?",
"url": "https://questionsmedicales.fr/mesh/D019887#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Agglutinine cacahuète",
"description": "Quelles complications peuvent survenir avec l'allergie ?\nLes complications sont-elles fréquentes ?\nComment gérer les complications ?\nLes complications peuvent-elles affecter la qualité de vie ?\nY a-t-il des risques à long terme ?",
"url": "https://questionsmedicales.fr/mesh/D019887#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Agglutinine cacahuète",
"description": "Quels sont les facteurs de risque d'allergie à l'agglutinine cacahuète ?\nL'âge joue-t-il un rôle dans le risque ?\nLes allergies saisonnières influencent-elles le risque ?\nLes conditions environnementales sont-elles un facteur ?\nLe mode de vie influence-t-il le risque d'allergie ?",
"url": "https://questionsmedicales.fr/mesh/D019887#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une allergie à l'agglutinine cacahuète ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un test cutané ou un dosage des IgE spécifiques peut confirmer l'allergie."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour l'agglutinine cacahuète ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests de provocation orale et les tests sanguins sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils aider au diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes comme l'urticaire ou l'anaphylaxie orientent vers un diagnostic."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'historique médical ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique des réactions allergiques aide à établir un diagnostic précis."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser des tests d'allergie standard ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests d'allergie standard peuvent être utilisés pour l'agglutinine cacahuète."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une allergie à l'agglutinine cacahuète ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent démangeaisons, urticaire, gonflement et difficultés respiratoires."
}
},
{
"@type": "Question",
"name": "L'anaphylaxie est-elle un symptôme possible ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'anaphylaxie est une réaction sévère pouvant survenir après exposition."
}
},
{
"@type": "Question",
"name": "Les symptômes apparaissent-ils rapidement ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent apparaître dans les minutes suivant l'exposition."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes digestifs associés ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des nausées, vomissements ou diarrhées peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils d'une personne à l'autre ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et le type de symptômes peuvent varier selon les individus."
}
},
{
"@type": "Question",
"name": "Comment prévenir une allergie à l'agglutinine cacahuète ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les arachides et lire attentivement les étiquettes des aliments est crucial."
}
},
{
"@type": "Question",
"name": "Les enfants peuvent-ils développer une allergie aux arachides ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'introduction précoce des arachides peut réduire le risque d'allergie."
}
},
{
"@type": "Question",
"name": "Des tests de dépistage sont-ils recommandés ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de dépistage peuvent être recommandés pour les enfants à risque élevé."
}
},
{
"@type": "Question",
"name": "Les parents doivent-ils être vigilants ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les parents doivent surveiller les réactions allergiques chez leurs enfants."
}
},
{
"@type": "Question",
"name": "Les allergies croisées sont-elles possibles ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des allergies croisées avec d'autres légumineuses peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal pour l'allergie à l'agglutinine cacahuète ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évitement des arachides est le traitement principal pour prévenir les réactions."
}
},
{
"@type": "Question",
"name": "Des médicaments peuvent-ils aider en cas de réaction ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antihistaminiques et l'épinéphrine sont utilisés pour traiter les réactions."
}
},
{
"@type": "Question",
"name": "Comment gérer une réaction anaphylactique ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'injection d'épinéphrine et l'appel aux urgences sont essentiels en cas d'anaphylaxie."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements à long terme ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de traitement à long terme pour l'allergie aux arachides."
}
},
{
"@type": "Question",
"name": "Les immunothérapies sont-elles efficaces ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études sur l'immunothérapie orale montrent des résultats prometteurs, mais pas encore validés."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec l'allergie ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'anaphylaxie, qui peut être mortelle sans traitement rapide."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications graves sont rares mais peuvent survenir chez les personnes sensibles."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une gestion rapide avec épinéphrine et soins médicaux est essentielle."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles affecter la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'anxiété liée aux réactions allergiques peut impacter la qualité de vie."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques à long terme ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les risques à long terme incluent des allergies persistantes et des réactions sévères."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque d'allergie à l'agglutinine cacahuète ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux d'allergies et les allergies alimentaires augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'âge joue-t-il un rôle dans le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants sont plus susceptibles de développer des allergies alimentaires."
}
},
{
"@type": "Question",
"name": "Les allergies saisonnières influencent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les allergies saisonnières peuvent coexister, mais n'influencent pas directement le risque."
}
},
{
"@type": "Question",
"name": "Les conditions environnementales sont-elles un facteur ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des allergènes environnementaux peut augmenter le risque d'allergies."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque d'allergie ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain peut réduire le risque d'allergies alimentaires."
}
}
]
}
]
}
From the Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany (A.R.); Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Cà Granda Ospedale Maggiore Policlinico, Milan, Italy (W.B.); the Centre for Waldenström's Macroglobulinaemia and Related Conditions, University College London Hospitals National Health Service Foundation Trust, London (S.D.); the Thrombosis and Hemostasis Center, Saitama Medical University Hospital, Saitama, Japan (Y.M.); the Division of Hematology, MedStar Georgetown University Hospital, Washington, DC (C.M.B.); the Department of Internal Medicine, Henri-Mondor University Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris-Est Créteil, Créteil, France (M.M.); the Division of Hematology, Massachusetts General Hospital, Harvard Medical School, Boston (D.J.K.), Bioverativ, Cambridge (J.F.), and Sanofi, Waltham (X.J., S.L., C.R., J.M.-A., W.H.) - all in Massachusetts; the Department of Clinical Pharmacology, Medical University of Vienna, Vienna (B.J.); and the Section for Hematology, Department of Medicine, Haukeland University Hospital, Bergen (T.H.A.T.), and the Department of Research and Innovation, Haugesund Hospital, Haugesund (S.B.) - both in Norway.
From the Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany (A.R.); Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Cà Granda Ospedale Maggiore Policlinico, Milan, Italy (W.B.); the Centre for Waldenström's Macroglobulinaemia and Related Conditions, University College London Hospitals National Health Service Foundation Trust, London (S.D.); the Thrombosis and Hemostasis Center, Saitama Medical University Hospital, Saitama, Japan (Y.M.); the Division of Hematology, MedStar Georgetown University Hospital, Washington, DC (C.M.B.); the Department of Internal Medicine, Henri-Mondor University Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris-Est Créteil, Créteil, France (M.M.); the Division of Hematology, Massachusetts General Hospital, Harvard Medical School, Boston (D.J.K.), Bioverativ, Cambridge (J.F.), and Sanofi, Waltham (X.J., S.L., C.R., J.M.-A., W.H.) - all in Massachusetts; the Department of Clinical Pharmacology, Medical University of Vienna, Vienna (B.J.); and the Section for Hematology, Department of Medicine, Haukeland University Hospital, Bergen (T.H.A.T.), and the Department of Research and Innovation, Haugesund Hospital, Haugesund (S.B.) - both in Norway.
Department of Pediatrics, Section of Allergy and Immunology, Children's Hospital Colorado, University of Colorado Denver School of Medicine, 13123 East 16th Avenue, Anschutz Medical Campus, Box 518, Denver, CO, USA. Matthew.Greenhawt@childrenscolorado.org.
From the Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany (A.R.); Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Cà Granda Ospedale Maggiore Policlinico, Milan, Italy (W.B.); the Centre for Waldenström's Macroglobulinaemia and Related Conditions, University College London Hospitals National Health Service Foundation Trust, London (S.D.); the Thrombosis and Hemostasis Center, Saitama Medical University Hospital, Saitama, Japan (Y.M.); the Division of Hematology, MedStar Georgetown University Hospital, Washington, DC (C.M.B.); the Department of Internal Medicine, Henri-Mondor University Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris-Est Créteil, Créteil, France (M.M.); the Division of Hematology, Massachusetts General Hospital, Harvard Medical School, Boston (D.J.K.), Bioverativ, Cambridge (J.F.), and Sanofi, Waltham (X.J., S.L., C.R., J.M.-A., W.H.) - all in Massachusetts; the Department of Clinical Pharmacology, Medical University of Vienna, Vienna (B.J.); and the Section for Hematology, Department of Medicine, Haukeland University Hospital, Bergen (T.H.A.T.), and the Department of Research and Innovation, Haugesund Hospital, Haugesund (S.B.) - both in Norway.
From the Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany (A.R.); Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Cà Granda Ospedale Maggiore Policlinico, Milan, Italy (W.B.); the Centre for Waldenström's Macroglobulinaemia and Related Conditions, University College London Hospitals National Health Service Foundation Trust, London (S.D.); the Thrombosis and Hemostasis Center, Saitama Medical University Hospital, Saitama, Japan (Y.M.); the Division of Hematology, MedStar Georgetown University Hospital, Washington, DC (C.M.B.); the Department of Internal Medicine, Henri-Mondor University Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris-Est Créteil, Créteil, France (M.M.); the Division of Hematology, Massachusetts General Hospital, Harvard Medical School, Boston (D.J.K.), Bioverativ, Cambridge (J.F.), and Sanofi, Waltham (X.J., S.L., C.R., J.M.-A., W.H.) - all in Massachusetts; the Department of Clinical Pharmacology, Medical University of Vienna, Vienna (B.J.); and the Section for Hematology, Department of Medicine, Haukeland University Hospital, Bergen (T.H.A.T.), and the Department of Research and Innovation, Haugesund Hospital, Haugesund (S.B.) - both in Norway.
From the Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany (A.R.); Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Cà Granda Ospedale Maggiore Policlinico, Milan, Italy (W.B.); the Centre for Waldenström's Macroglobulinaemia and Related Conditions, University College London Hospitals National Health Service Foundation Trust, London (S.D.); the Thrombosis and Hemostasis Center, Saitama Medical University Hospital, Saitama, Japan (Y.M.); the Division of Hematology, MedStar Georgetown University Hospital, Washington, DC (C.M.B.); the Department of Internal Medicine, Henri-Mondor University Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris-Est Créteil, Créteil, France (M.M.); the Division of Hematology, Massachusetts General Hospital, Harvard Medical School, Boston (D.J.K.), Bioverativ, Cambridge (J.F.), and Sanofi, Waltham (X.J., S.L., C.R., J.M.-A., W.H.) - all in Massachusetts; the Department of Clinical Pharmacology, Medical University of Vienna, Vienna (B.J.); and the Section for Hematology, Department of Medicine, Haukeland University Hospital, Bergen (T.H.A.T.), and the Department of Research and Innovation, Haugesund Hospital, Haugesund (S.B.) - both in Norway.
Department of Pediatrics, Division of Allergy and Immunology, UNC School of Medicine, Chapel Hill, NC; UNC Food Allergy Initiative, Department of Pediatrics, UNC School of Medicine, Chapel Hill, NC.
The three dimensional structure of a protein is very important for its structure. Studies relating to protein structure have been numerous and the effect of denaturants on proteins can help understand...
Cold agglutinin disease (CAD) is a rare type of autoimmune hemolytic anemia (AIHA) distinct from warm antibody AIHA. One of the ways it is distinct is that CAD is usually not responsive to corticoster...
Cold agglutinin disease (CAD) is a rare autoimmune hemolytic anemia and a bone marrow clonal lymphoproliferative disorder. Hemolysis in CAD is complement-dependent and mediated by the classical activa...
Peanuts are highly valued for their abundance of essential nutrients and health-promoting phenolic compounds. Peanut press cake, an inexpensive and underutilized agro-industrial by-product of oil prod...
Primary cold agglutinin disease (CAD) is a rare autoimmune hemolytic anemia caused by cold-reactive antibodies that bind to red blood cells and lead to complement-mediated hemolysis. Patients with pri...
Cold agglutinin disease (CAD) is a difficult-to-treat autoimmune hemolytic anemia and B cell lymphoproliferative disorder associated with fatigue, acrocyanosis, and a risk of thromboembolic events. Co...
This review summarizes clinical and experimental antibody-based treatments for CAD and analyzes the risks and benefits of B cell and complement directed therapies, and discusses potential future treat...
Conventional treatment of CAD includes a B cell targeted treatment approach with rituximab, yielding only limited treatment success. The addition of a cytotoxic agent (e.g. bendamustine) increases eff...
The 14-3-3 protein is a kind of evolutionary ubiquitous protein family highly conserved in eukaryotes. Initially, 14-3-3 proteins were reported in mammalian nervous tissues, but in the last decade, th...
The Expert Panel for Cosmetic Ingredient Safety reviewed updated information that has become available since their original assessment from 2001, along with updated information regarding product types...
Soybeans are the main source of oils and protein for humans and animals; however, cold stress jeopardizes their growth and limits the soybean planting area. Aldehyde dehydrogenases (ALDH) are conserve...